Clinical Trials Browser

Unknown × Lung Neoplasms × Drug Therapy × Clear all

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05873790 2023-05-24

Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study

Unknown

30 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT02428049 2023-01-20

Radiation Pneumonitis After SBRT for NSCLC

Unknown

105 enrolled

Thoracic

Lung Neoplasms

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Phase 2 Unknown

63 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03664115 2018-09-10

Itraconazole in Non Small Cell Lung Cancer

Phase 2 Unknown

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03589950 2018-07-18

Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Unknown

60 enrolled

Thoracic

Lung Neoplasms

NCT02771756 2016-05-13

The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

Phase NA Unknown

300 enrolled

BreastThoracic

Breast Neoplasms, Lung Neoplasms

NCT01624051 2014-09-30

A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

Phase 2 Unknown

144 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Sarcopenia

NCT00039039 2013-12-18

Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Phase 3 Unknown

300 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01850147 2013-05-09

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

Phase 2 Unknown

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00452803 2010-07-12

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

102 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study

Radiation Pneumonitis After SBRT for NSCLC

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Itraconazole in Non Small Cell Lung Cancer

Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)